Prevalence of multiple sclerosis (MS) in Zanjan province of Iran

Ghajarzadeh, Mahsa; Foroushani, Abbas Rahimi; Ghezelbash, Parviz; Ghoreishi, Abdoreza; Maghbooli, Mehdi; Yousefi, Mehran; Rahgoshai, Babak K; Maemodan, Farhad Golipoor; Mohammadifar, Mehdi; Sahraian, Mohammad Ali

doi:10.4103/ijpvm.ijpvm_419_19

Cited by 9 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Multiple sclerosis (MS) is a degenerative, neurologic disease of the central nervous system (CNS) affecting women more than men [ 1 ]. It usually occurs between 20 and 50 years of age, while MS-related complications include both physical and psychological consequences [ 2 ].…”

Section: Introductionmentioning

confidence: 99%

Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis

et al. 2023

Self Cite

View full text Add to dashboard Cite

Objective To estimate the pooled prevalence of sexual dysfunction (SD) in women with multiple sclerosis (MS). Methods We systematically searched PubMed, Scopus, EMBASE, Web of Science, and google scholar and also gray literature up to October 2021. The search strategy includes: (“Multiple Sclerosis” OR “MS” OR “Disseminated Sclerosis” OR (Disseminated AND Sclerosis) OR (Sclerosis AND Multiple)) AND (“Sexual Dysfunction” OR (Sexual AND Dysfunction) OR (Sexual AND Dysfunctions) OR (Sexual AND Disorders) OR (Sexual AND Disorder) OR “Sexual Dysfunctions” OR “Sexual Disorders” OR “Sexual Disorder” OR “Psychosexual Dysfunctions” OR (Dysfunction AND Psychosexual) OR (Dysfunctions AND Psychosexual) OR “Psychosexual Dysfunction” OR “Psychosexual Disorders” OR (Disorder AND Psychosexual) OR (Disorders AND Psychosexual) OR “Psychosexual Disorder” OR “Hypoactive Sexual Desire Disorder” OR “Sexual Aversion Disorder” OR (Aversion Disorders AND Sexual) OR (Disorders AND Sexual Aversion) OR “Sexual Aversion Disorders” OR “Orgasmic Disorder” OR (Disorders AND Orgasmic) OR “Orgasmic Disorders” OR “Sexual Arousal Disorder” OR (Arousal Disorders AND Sexual) OR (Disorders AND Sexual Arousal) OR “Sexual Arousal Disorders” OR “Frigidity”). Results We found 2150 articles by literature search, after deleting duplicates 1760 remained. Fifty-six articles remained for meta-analysis. The pooled prevalence of SD in MS patients estimated as 61% (95%CI:56–67%) (I2:95.7%, P < 0.001). The pooled prevalence of Anorgasmia in MS patients estimated as 29% (95%CI:20–39%) (I2:85.3%, P < 0.001). The pooled odds of developing SD in MS women estimated as 3.05(95%CI: 1.74–5.35) (I2:78.3%, P < 0.001). The pooled prevalence of decreased vaginal lubrication in MS patients estimated as 32%(95%CI:27–37%) (I2 = 94.2%, P < 0.001). The pooled prevalence of reduced libido was 48%(95%CI:36–61%) (I2:92.6%, P < 0.001). The pooled prevalence of arousal problems was 40%(95%CI: 26–54%) (I2:97.4%, P < 0.001). The pooled prevalence of intercourse satisfaction was 27% (95%CI: 8–46%) (I2:99%, P < 0.001). Conclusion The result of this systematic review and meta-analysis show that the pooled prevalence of SD in women with MS is 61% and the odds of developing SD in comparison with controls is 3.05.

show abstract

Section: Introductionmentioning

confidence: 99%

Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis

et al. 2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…Multiple sclerosis (MS) is an autoimmune disease of central nervous system (CNS) [ 1 , 2 ], affecting youth all over the world. The exact etiology of the disease is unknown, but multiple putative etiologic factors have been considered to play a role in development of MS [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

Is Celiac Disease (CD) Prevalent in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis

Olfati

Ghoshouni

Ebrahimi

et al. 2022

Multiple Sclerosis International

Self Cite

View full text Add to dashboard Cite

Background. Celiac disease (CD) is an autoimmune disease, and its prevalence reported variously in different studies. The goal of this study is to evaluate the pooled prevalence of CD in subjects with MS. Methods. PubMed, Scopus, EMBASE, Web of Science, and Google Scholar along with gray literature were systematically searched. The search included all relevant studies which were published up to October 2022. Two researchers independently searched all databases and also references of included studies. Results. We found 8211 articles by literature search, and after deleting duplicates, 5594 remained. Fifteen articles remained for meta-analysis. Totally, 31418 patients were evaluated, and the total number of possible/confirmed cases was 124. Studies were published between 2004 and 2020, and the most published studies were from Italy. Five studies provided information regarding controls. The total number of controls was 22394, of whom 22 had CD. Mean age ranged from 35 to 55 years. The pooled prevalence of CD in MS patients was 0 ( I 2 = 88.2 %, p < 0.001 ). The pooled odds of CD in subjects with MS are 0.46 (95% CI: 0.19-1.1) ( I 2 = 0 , p = 0.9 ). Conclusion. The pooled prevalence of this systematic review showed that CD is not prevalent in MS cases.

show abstract

Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis

et al. 2021

View full text Add to dashboard Cite

Prevalence of multiple sclerosis (MS) in Zanjan province of Iran

Cited by 9 publications

References 21 publications

Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis

Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis

Is Celiac Disease (CD) Prevalent in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis

Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis

Contact Info

Product

Resources

About